SENP1 and acute myeloid leukemia: In addition, exploring the BLOODSPOT database, we found that the expression level of SENP1 in AML with adverse prognosis karyotypes, such as complex karyotypes, was significantly higher than that in AML with favorable prognosis karyotypes, such as t(15,17) (Fig. 1F) [20].